日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer in a Randomized Phase IIa Trial.

在一项随机 IIa 期试验中,姜黄素联合 FOLFOX 化疗对转移性结直肠癌患者安全且耐受性良好

Howells Lynne M, Iwuji Chinenye O O, Irving Glen R B, Barber Shaun, Walter Harriet, Sidat Zahirah, Griffin-Teall Nicola, Singh Rajinder, Foreman Nalini, Patel Samita R, Morgan Bruno, Steward William P, Gescher Andreas, Thomas Anne L, Brown Karen

Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy

姜黄素在体外结直肠癌肝转移模型中抑制癌干细胞表型,并且与FOLFOX化疗联合使用具有临床安全性和耐受性。

James, Mark I; Iwuji, Chinenye; Irving, Glen; Karmokar, Ankur; Higgins, Jennifer A; Griffin-Teal, Nicola; Thomas, Anne; Greaves, Peter; Cai, Hong; Patel, Samita R; Morgan, Bruno; Dennison, Ashley; Metcalfe, Matthew; Garcea, Giuseppe; Lloyd, David M; Berry, David P; Steward, William P; Howells, Lynne M; Brown, Karen